Company / Free Cash Flow
STANDARD BIOTOOLS INC. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$46.1M
FY2025
5-year range
-$93.2M / -$37.7M
FY2021-FY2025
Trend
+50.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$93M to -$46M over the past 2 years.
Based on SEC 10-K filings.
-$46M in FY2025.
Improved from -$93M to -$46M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 50.5% year-over-year.
- Peak free cash flow was recorded in FY2020.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$46.1M | +50.5% |
| FY2024 | -$93.2M | +0.0% |
| FY2023 | -$93.2M | -62.6% |
| FY2022 | -$57.3M | -51.9% |
| FY2021 | -$37.7M | -47.6% |
| FY2020 | -$25.6M | +0.4% |
| FY2019 | -$25.7M | +41.9% |
| FY2018 | -$44.2M | -14.2% |
| FY2017 | -$38.7M | -28.9% |
| FY2016 | -$30.0M | -496.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026